BREGE LAURA 1365619 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-05 | 2021-06-22 | 2021-06-22 to 2023-06-01 | 4 | Brege Laura | DIRECTOR | acq | 18002.0 | 100.0 | 1.11 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 18002.0
|
162.63 (ACAD) |
| 2023-06-07 | 2023-06-05 | 2023-06-05 | 4 | Brege Laura | DIRECTOR | dsp | 600.0 | 5.91 | 0.13 | 38.74 | Direct | Common Stock | PACIRA BIOSCIENCES, INC. | code S | 9547.0 | 45.99 (PCRX) |
| 2023-06-14 | 2023-06-12 | 2023-06-12 | 4 | Brege Laura | DIRECTOR | dsp | 4500.0 | 25.0 | 0.28 | 24.87 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 13502.0 | 162.63 (ACAD) |
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Brege Laura | DIRECTOR | acq | 1775.0 | 15.68 | 0.39 | 0.0 | Direct | Common Stock | PACIRA BIOSCIENCES, INC. | code A | 11322.0 | 45.99 (PCRX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-05 | 2021-06-22 | 2023-06-01 | 4 | Brege Laura | DIRECTOR | acq | 11045.0 | 100.0 | 0.68 | 23.9 | Direct | Director Stock Options (Right To Buy) | ACADIA PHARMACEUTICALS INC | code A | 11045.0 | 162.63 (ACAD) |
| 2023-06-05 | 2021-06-22 | 2021-06-22 to 2023-06-01 | 4 | Brege Laura | DIRECTOR | dsp | 18002.0 | 100.0 | 1.11 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 0.0
|
162.63 (ACAD) |
| 2023-06-05 | 2021-06-22 | 2023-06-01 | 4 | Brege Laura | DIRECTOR | acq | 6652.0 | 100.0 | 0.41 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code A | 6652.0 | 162.63 (ACAD) |
| 2023-06-14 | 2023-06-12 | 2023-06-12 | 4 | Brege Laura | DIRECTOR | acq | 22123.0 | 100.0 | 3.5 | 9.55 | Direct | Stock Option (Right To Buy) | EDGEWISE THERAPEUTICS, INC. | code A | 22123.0 | 63.28 (EWTX) |
| 2023-06-14 | 2023-06-12 | 2023-06-12 | 4 | Brege Laura | DIRECTOR | acq | 17000.0 | 100.0 | 4.47 | 28.97 | Direct | Stock Option (Right To Buy) | MIRUM PHARMACEUTICALS, INC. | code A | 17000.0 | 38.03 (MIRM) |
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Brege Laura | DIRECTOR | acq | 12925.0 | 100.0 | 2.81 | 38.74 | Direct | Stock Option (Right To Buy) | PACIRA BIOSCIENCES, INC. | code A | 12925.0 | 45.99 (PCRX) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)